Consegna Pharma Highlights Innovative Modeling and Simulation Strategy as FDA Concurs with Regulatory Pathway for CP217 to Prevent Fentanyl Epidemic Deaths
PR Newswire —
Prevention of Renarcotization after Rescue from Opioid Overdose is a New Indication and Planned Clinical Studies will be Supported by Pioneering a First-of-Its-Kind, Capital Efficient, Modeling and Simulation-Driven 505(b)(2) Pathway PITTSBURGH, Feb. 24, 2026 /PRNewswire/ -- Consegna...